Release according to Article 135, Section 1 BörseG with the objective of Europe-wide distribution
EQS Total Voting Rights Announcement: Marinomed Biotech AG / Total Voting
   Rights Announcement
   Marinomed Biotech AG: Release according to Article 135, Section 1 BörseG
   with the objective of Europe-wide distribution

   31.12.2024 / 10:00 CET/CEST
   Total Voting Rights Announcement according to Article 135, Section 1 of
   the BörseG transmitted by EQS News - a service of EQS Group.
   The issuer is solely responsible for the content of this announcement.

   ══════════════════════════════════════════════════════════════════════════

   Marinomed Biotech AG herewith announces pursuant to Sec. 135 Para. 1 of
   the Stock Exchange Act, that due to the resolution on the capital increase
   of December 05, 2024, the total number of voting rights as at the end of
   December 2024 has increased to 1,778,333 voting rights, and the Company's
   new share capital amounts to EUR 1,778,333. The change in the total number
   voting rights took effect upon entry in the commercial register on
   December 19, 2024.

   ══════════════════════════════════════════════════════════════════════════

   31.12.2024 CET/CEST

   ══════════════════════════════════════════════════════════════════════════

   Language: English
   Company:  Marinomed Biotech AG
             Hovengasse 25
             2100 Korneuburg
             Austria
   Internet: www.marinomed.com


    
   End of News EQS News Service


   2055907  31.12.2024 CET/CEST

result hk

slot demo

slot demo

result hk

By adminn